More Articles

Canada approves enoxaparin biosimilars Inclunox and Noromby Biosimilars/News | Posted 20/11/2020

Canada’s drug regulator, Health Canada, has approved the enoxaparin sodium biosimilars Inclunox and Noromby.

Discontinuation following biosimilar switching in IBD patients Biosimilars/Research | Posted 20/11/2020

Medical management of inflammatory bowel diseases (IBD) has significantly improved since the introduction of biological therapies over the past 20 years. The adoption of biologicals in IBD care has...

Biosimilars trend report 2020 Reports | Posted 20/11/2020

The seventh edition of the Biosimilars Trend Report 2020 has been published. This 2020 report was developed based on input from members of the healthcare community in the US [1].

Alberta Biosimilars Initiative: switching policy updates in Canada Biosimilars/General | Posted 20/11/2020

The Alberta government in Canada has announced updates to the Alberta Biosimilars Initiative. 

Global harmonization of GMP standards for biologicals Biosimilars/Research | Posted 20/11/2020

Biopharmaceuticals are complex as their active pharmaceutical ingredient (API) is manufactured using living systems. In turn, this leads to complex manufacturing processes. A recent GaBI Journal [1...

Biden vows to protect Obamacare and increase reliance on quality generics Policies & Legislation | Posted 20/11/2020

President-elect Joe Biden plans to protect and strengthen the Affordable Care Act, the public health insurance scheme passed in 2010 by then President Barack Obama. Over the last few years, the Aff...

China prioritizes drug innovation while increasing access to drugs approved abroad Generics/General | Posted 20/11/2020

China's pharmaceutical industry is undergoing a transformation towards high-quality and innovation-focused development, which has led to an explosion of new drug and clinical trial approvals in rec...

Teva launches first Truvada and Atripla generics and two digital inhalers Generics/News | Posted 20/11/2020

On 2 October 2020, Teva Pharmaceuticals announced the launch of the first US Food and Drug Administration (FDA) approved generic versions of Truvada (emtricitabine 200 mg/tenofovir disoproxil fumar...